Question

A 63-year-old woman with longstanding type 2 diabetes and prior myocardial infarction is on maximum tolerated metformin. Her HbA1c remains 8.0% (64 mmol/mol). eGFR is 60 mL/min/1.73 m² and she has microalbuminuria. What additional agent is preferred to improve cardiovascular and renal outcomes?

Accepted Answer

An SGLT2 inhibitor

Answer

A sulfonylurea such as gliclazide

Answer

A thiazolidinedione such as pioglitazone

Answer

A DPP-4 inhibitor

Answer

Basal human insulin

Practice question

A 63-year-old woman with longstanding type 2 diabetes and prior myocardial infarction is on maximum tolerated metformin. Her HbA1c remains 8.0% (64 mmol/mol). eGFR is 60 mL/min/1.73 m² and she has microalbuminuria. What additional agent is preferred to improve cardiovascular and renal outcomes?